Cost-effectiveness of antihypertensive treatment in patients 80 years of age or older in Switzerland: an analysis of the HYVET study from a Swiss perspective

This analysis shows the economic benefit of antihypertensive treatment in patients 80 years of age or older from the perspective of the Swiss healthcare system. The cost-effectiveness analysis of antihypertensive treatment in the elderly was carried out applying the results of the Hypertension in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Szucs, T D, Waeber, B, Tomonaga, Y
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3011095/
https://www.ncbi.nlm.nih.gov/pubmed/19536166
http://dx.doi.org/10.1038/jhh.2009.47

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3011095/
https://www.ncbi.nlm.nih.gov/pubmed/19536166
http://dx.doi.org/10.1038/jhh.2009.47

Ejemplares similares